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’ INTRODUCTION
Characterization of a drug molecule becomes extremely im-
portant when it is related with one of the detrimental diseases and
very few of such drugs are available for the management of such
diseases. Tuberculosis (TB) is an example of such disease for
which limited number of antibiotics, for example, Rifampicin,
Isoniazid, and Ethambutol, are the essential choices for the
clinical disease management.1-7 Among others, Rifampicin
(RF) is a potent antituberculosis drug and has enormous phar-
macological significance. It is a very effective antibiotic, particu-
larly active againstMycobacterium tuberculosis,M. bovis,M. avium
complex, andM. intracellulare,8-12 and hence it is highly effective
in the treatment of TB. It is known that RF is a specific inhibitor
of bacterial RNA polymerase, which acts by direct interaction
with the enzyme,13 probably by inhibiting the process of tran-
scription at the level of initiation.14-16 Although, RF is poorly
soluble in aqueous media,17 it is a clinically effective drug. The
inescapable necessity and poor solubility of RF automatically
necessitates an alternate drug delivery/carrier system.17-21 In
this regard, the interaction of RF with various potential drug
carrier systems is essential. However, such studies on the
encapsulation of the drug in other macromolecules/molecular
assemblies in present literature are sparse. One of the early
conductometry studies investigated the interaction of the drug
with β-cyclodextrin, a potential drug delivery system.22 It is well-
known that macromolecular assemblies like micelles are also very
efficient drug delivery system for the solubilization of hydro-
phobic drugs.23,24 However, until date no study has been initiated
on the interaction of the vital drug RF with micelles. Exploration
of the binding interaction of the anti-TB drug, RF with a model
micelle (sodium dodecyl sulfate; SDS) is the motive of the
present work. Although, the drug RF has very distinct spectro-
scopic signature including optical absorption and circular dichro-
ism (CD), the spectroscopic properties have not been used in
earlier studies to investigate the interaction of the drug with other
macromolecular assembly.
Here, dynamic light scattering (DLS) and conductometric
techniques have been used to investigate the integrity of the
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ABSTRACT: In this contribution, we report studies on the nature of
binding of a potent antituberculosis drug, Rifampicin (RF) with a model
drug delivery system, sodium dodecyl sulfate (SDS) micelle. Tempera-
ture dependent dynamic light scattering (DLS), conductometry, and
circular dichroism (CD) spectroscopy have been employed to study the
binding interaction of the drug with the micelle. The absorption
spectrum of the drug RF in the visible region has been employed to
study F€orster resonance energy transfer (FRET) from another fluor-
escent drug Hoechst 33258 (H33258), bound to the micelle. Picose-
cond-resolved FRET studies at room temperature confirm the
simultaneous binding of the two drugs to the micelle and the distance
between the donor-acceptor pair is found to be 34 Å. The temperature
dependent FRET study also confirms that the location and efficiency of
drug binding to the micelle changes significantly at the elevated
temperature. The energy transfer efficiency of the donor H33258, as
measured from time-resolved studies, decreases significantly from 76% at 20 C to 60% at 55 C. This reveals detachment of some
amount of the drug molecules from the micelles and increased donor-acceptor distance at elevated temperatures. The estimated
donor-acceptor distance increases from a value of 33 Å at 20 C to 37 Å at 55 C. The picosecond resolved FRET studies on a
synthesized DNA bound H33258 in RF solution have been performed to explore the interaction between the two. Our studies are
expected to find relevance in the exploration of a potential vehicle for the vital drug rifampicin.
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nanoscopic macromolecular assembly of SDS micelle upon
binding of the drug RF. We have also used CD spectroscopy
to explore the binding interaction of the drug with the SDS
micelle and also to investigate the thermal stability of the drug-
micelle complex. The optical absorption spectrum of the drug RF
in the visible region has been exploited for the dipolar interaction
with another, micelle-bound fluorescent antihelmenthic drug,
Hoechst 33258 (H33258). Here time-correlated single photon
counting (TCSPC) spectroscopy has been utilized to investigate
the coexistence of the drug with H33258 and also to locate the
binding of the same with respect to H33258, bound to the
macromolecular SDS micellar assembly. Temperature-depen-
dent F€orster resonance energy transfer (FRET) studies from
the donor H33258 to the acceptor RF at the micellar surface
confirm the physical attachment of the drug RF to the SDS
micelle and the thermal stability of the simultaneous drug
binding capability of the host micelle. We have also used FRET
to study the interaction of the drug RF with a synthesized
dodecamer DNA. The studies are expected to find its relevance
in the exploration of alternate drug delivery systems for the
poorly aqueous soluble drug like RF.
’MATERIALS AND METHODS
Hoechst 33258 (H33258) was purchased from Molecular
probes. Rifampicin, sodium dihydrogen phosphate, and diso-
dium hydrogen phosphate (for the preparation of phosphate
buffer) were purchased from Sigma. Sodium dodecyl sulfate
(SDS) was purchased from Fluka and used without any further
purification. Dodecamer (50CGCGAATTCGCG30) DNA was
purchased from Trilink (USA). A 100 mM phosphate buffer
(pH 7) was prepared by using sodium dihydrogen phosphate
(50 mM), disodium hydrogen phosphate (50 mM) in Millipore
water and the sample solutions were prepared in the same.
The DLS measurements were done in a Nano S Malvern-
instrument employing a 4 mW He-Ne laser (λ = 632.8 nm)
equipped with a thermostatic sample chamber. All the scattered
photons were collected at 173 scattering angle. The scattering
intensity data were processed using the instrumental software to
obtain the hydrodynamic diameter (dH) and the size distribution
of the scatterer in each sample. The instrument measures the
time dependent fluctuation in the intensity of light scattered from
the particles in solution at a fixed scattering angle. Hydrodynamic
diameter of the clusters was estimated from the intensity auto-
correlation function of the time-dependent fluctuation in inten-
sity. Hydrodynamic diameter is defined as dH = (kbT)/(3πηD)
where, kb is the Boltzmann constant, η is the solvent (here,
water) viscosity, and D is the translational diffusion coefficient.
The resolution of the instrument is 0.6 nm.
The conductivity of mixtures was measured with two platinum
electrodes and digital conductivity bridge, Sensino 378 conduc-
tivity meter. Measurement of conductivity was carried out with
an absolute accuracy up to (0.5%. An accuracy of (0.3 C was
assured in the temperature-dependent experiments. The con-
ductivity measurements were done at different temperatures for
SDS/buffer binary system and for SDS/RF/buffer ternary sys-
tem, as a function of SDS concentration keeping RF concentra-
tion constant at 2 10-4M. CDmeasurements were carried out
on a JASCO 815 spectro-polarimeter with a temperature con-
troller attachment. The scan speed of the measurements was
50 nm/min and each spectrum was the average of five scans.
Buffer solutions containing the corresponding concentration of
the surfactant, that is, SDS, were subtracted from all the
measurements. The concentration of the drug RF was 43 
10-6 M, and the SDS concentration was varied from 1 10-3 to
50  10-3 M. The results were expressed in θ, the optical
rotation obtained from the instrument in millidegrees and also as
molar ellipticity [θ] in M 3 cm 3mdegrees
-1. The temperature
dependent CD experiments were done on taking 11  10-6 M
RF and SDS of concentration 8  10-3 and 20  10-3 M. All
absorbance measurements were performed in a Shimadzu UV-
2450 spectrophotometer and fluorescence measurements were
performed in a Jobin Yvon Fluoromax-3 fluorimeter. For the
steady state fluorescence experiments, 11.47 10-6 M H33258
and 20.13  10-3 M SDS were used and RF concentration was
maintained at 1  10-4 M.
The details of the picosecond-resolved spectroscopic data
(including transients and time-resolved anisotropy) were mea-
sured with commercially available time correlated single photon
counting (TCSPC) setup from Edinburgh Instruments (instru-
ment response function, IRF = 60 ps), in which the sample was
excited at 375 nm. The picosecond-resolved fluorescence tran-
sients have been fitted with triexponential function, ∑i=l
3 Ai exp
(-t/τi), where, Ai’s are weight percentages of the decay compo-
nents with time constants of τi. The relative change in the overall
excited state lifetime is expressed by the equation τ = ∑i=l
3 Aiτi,
when ∑i=l
3 Ai = 1. For the energy transfer experiments,
25 the
concentration of H33258 was 11.47  10-6 M whereas, for RF
and SDS, it was 182  10-6 and 20  10-3 M respectively. We
have used 8 10-6 M of H33258, 10 10-6 MDNA, and 50
10-6 M RF to investigate the possibility of binding of RF to
DNA. The F€orster resonance energy transfer distances of
donor-acceptor pairs were calculated using the equation25
R0 ¼ 0:211½k2n-4QDJðλÞ1=6ðIn ÅÞ ð1Þ
where R0 is the distance between the donor and the acceptor at
which the energy transfer efficiency is 50%, and κ2 is a factor
describing the relative orientation of the transition dipoles of the
donor and acceptor in space. The acceptor RF can bind to the
micelle at any orientation with respect to the donor H33258.
Thus for an ensemble of donor-acceptor (D-A) pairs the
relative orientation of the D-A is not supposed to be constant
and the magnitude of κ2 is assumed to be two-thirds for donor
and acceptors. The refractive index (n) of the medium was
assumed to be 1.4 (aqueous medium).QD, the quantum yields of
the donor in the absence of acceptor were reported for H33258-
micelle and H33258-DNA to be 0.54 and 0.53, respectively.26
J(λ), the overlap integral, which expresses the degree of spectral
overlap between the donor emission and the acceptor absorp-
tion, is given by
JðλÞ ¼
R¥
0 FDðλÞεAðλÞλ4 dλR¥
0 FDðλÞdλ
ð2Þ
where FD (λ) is the fluorescence intensity of the donor in the
wavelength range of λ to λ þ dλ and is dimensionless. εA (λ) is
the extinction coefficient (inM-1 cm-1) of the acceptor at λ. If λ
is in nanometers, then J(λ) is in units of M-1 cm-1 nm4. Once
the value of R0 is known, the donor-acceptor distance (rDA) can
easily be calculated using the formula
r6DA ¼
½R60ð1- EÞ
E
ð3Þ
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Here, E is the efficiency of energy transfer. The transfer efficiency
can be measured using the relative fluorescence intensity of the
donor in the absence (FD) and presence (FDA) of the acceptor
(eq 4a). The efficiency, E can also be calculated from the lifetimes
(τD and τDA) using the eq 4b, where τD and τDA are lifetimes of
the donor in absence and in presence of the acceptor, respectively.
E ¼ 1- FDA
FD
ð4aÞ
E ¼ 1- τDA
τD
ð4bÞ
The potential danger of using the eq 4a for the estimation of
resonance energy transfer has been discussed earlier.27 For
anisotropy (r(t)) measurements, emission polarization was
adjusted to be parallel or perpendicular to that of the excitation
and anisotropy is defined as
rðtÞ ¼ ½Ipara - GIperp½Ipara þ 2GIperp ð5Þ
whereG, the grating factor, is determined following tail matching
technique28 and found out to be nearly 1. The time-resolved
anisotropy of a fluorophore/probe reveals the physical motion of
the probe in a microenvironment. The time constants reflect
rotational correlation time of the probe in the microenviron-
ment.
’RESULTS AND DISCUSSIONS
As RF is hydrophobic in nature, it can bind to nanoscopic
macromolecular assembly of SDS, which is amphiphilic in
nature.29 The sizes of the micelles are determined using the
DLS measurements. It is observed that SDS micelles produce
spherical and monodispersed droplets, in aqueous buffer, of
hydrodynamic diameter (dH) of ∼4 nm (inset of Figure 1a).
As shown in Figure 1a, the hydrodynamic diameter of the micelle
remains unaltered upon binding of RF. Given the fact that RF is
an amphoteric molecule and at pH 7 it remains in Zwitterionic
form30 interacting with the headgroup of the SDS micelle, the
drug is expected to stay at the micelle-water interface.
Figure 1b depicts the stability of RF-SDS micelle complex at
various temperatures. The average hydrodynamic diameter of
SDS micelle-RF complex at room temperature of 4.85 nm
(25 C) does not change appreciably when temperature is
increased up to 70 C (inset of Figure 1b). Therefore, it indicates
that SDS micelle-RF complex maintains its nanoscopic assem-
bly even at higher temperature. However, a change in the
scattering intensity is observed with increase in temperature
which can be attributed to the increase in the critical micellar
concentration (CMC) of the SDSmicelle resulting in decrease in
the number of SDS micelles at 70 C.
Figure 2a shows the variation of conductivity of the SDS/
buffer binary solution as a function of SDS concentration. It is
Figure 1. (a) Scattering intensity of 50 mM SDS micelle-RF (RF þ
SDS) complex as obtained from the DLS study. A typical DLS signal of
SDS micelles without RF at 35 C has been depicted in the inset. (b)
Scattering intensity of 50 mM SDS micelle-RF complex at tempera-
tures 25 and 70 C. Inset shows the hydrodynamic diameters of the SDS
micelle-RF complex at different temperatures.
Figure 2. Conductivity (κ) plots. (a) SDS/buffer (SDS) binary system
and (b) SDS/RF/buffer (SDSþRF) ternary systemwith varying [SDS]
concentration keeping the RF concentration constant.
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evident from the figure that upon addition of SDS, it occupies the
free space available in the system and thus increases the
conductivity. When the concentration of SDS is high (CMC
and above), it favors self-association of SDS molecules to form
micelle. CMC is determined by the intersection of the two
straight lines of the conductivity-concentration plots22 and is
found to be 5 mM in our experimental condition rather than
8 mM, which is the expected value of CMC for SDS in water. It
could be due to the presence of electrolytes, which causes a
decrease in the CMC value of the ionic surfactant.31 Figure 2b
shows the variation of conductivity of SDS/RF/buffer ternary
system. In Figure 2b, some significant change in the point of
intersection of two lines (from 5 to 8mM) is observed, where RF
concentration is kept constant (0.2 mM) and the SDS concen-
tration is varied. The break point (CMC of SDS) in presence of
RF is shifted to relatively higher SDS concentration (8 mM). In
an earlier study, on the complexation of β-cyclodextrin with the
drug RF, similar conductometric patterns have been reported to
confirm the binding of the drug with the cyclodextrin molec-
ules.22 The temperature-dependent conductivity of SDS/buffer
and SDS/RF/buffer system has also been performed; however,
no significant change in the slope of the conductivity-concen-
tration plot is evident (results not shown).
RF has a remarkable CD characteristic32 that makes the CD
spectroscopy a suitable tool to study the effect of RF-binding to
the SDSmolecules. CD studies have been done on RF and SDS-
RF complex in phosphate buffer at pH 7. On complexation with
SDS, RF shows a change in CD band intensity as depicted in
Figure 3. The inset of Figure 3 shows the absorption spectra of
RF that does not alter significantly upon addition of SDS. The
UV-vis spectroscopy is unable to provide any information of the
interaction of RF with SDS, as shown in the inset of Figure 3. The
Figure 3. Optical rotation (mdeg) of RF with increasing concentration
of SDS (0-50 mM). The inset shows the optical density of RF with
increasing concentration of SDS.
Figure 4. (a) Optical rotation (mdeg) of 8  10-3 M SDS-RF
complex with increasing temperatures. Inset shows the optical rotation
(mdeg) of SDS-RF complex at 330 nm with increasing temperatures.
(b) Optical rotation (mdeg) of 20  10-3 M SDS-RF complex with
increasing temperatures. Inset shows the optical rotation (mdeg) of
SDS-RF complex at 330 nm with increasing temperatures.
Figure 5. (a) Steady state absorption spectra of Rifampicin (RF; violet)
and emission spectra of H33258-SDS (SDS-H; green) are shown. An
overlapping zone between emission of H33258 and absorption of
acceptor RF is indicated as yellow shaded zone. Inset shows the
steady-state emission of SDS-H33258 (SDS-H) and SDS-RF-
H33258 complex (SDS-RF-H). (b) The picosecond resolved fluor-
escence transients of SDS-H33258 (SDS-H) in absence (green) and
in presence (red) of acceptor RF. Inset shows the fluorescence anisot-
ropy, r(t) of SDS-H33258 (SDS-H) complex. Excitation wavelength
is 375 nm and data collected at 475 nm wavelength.
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effect of temperature on the binding of RF to the SDS surfactant,
near and far above the critical micellar concentrations, is exam-
ined by the temperature-dependent CD measurements and is
depicted in Figure 4a,b, respectively. The CD spectra of the
SDS-RF complex taken at different temperatures are analyzed
to determine the change in ellipticity of the drug bound to the
micelle. It is observed that the negative ellipticity of SDS-RF
complex at 330 nm decreases with increasing the temperature
from 20 to 90 C for both the cases (near and far above the
CMC). The nature of the slopes of the CD plots as shown in the
insets of Figure 4a,b are similar. The observation clearly indicates
that RF detaches from the micelle at higher temperature and it is
independent of SDS concentration.
To confirm the binding of RF to the SDS micelle, another
fluorescent dye H33258, bound to the SDS micelle, has been
utilized. The emission spectrum of the dye H33258 in buffer
shows a peak at 505 nm, which becomes blue shifted in
hydrophobic environment (475 nm in SDSmicelles),26 as shown
in Figure 5a. The binding of the donor drug H33258 to the
micelle is confirmed by time-resolved anisotropy study. The
fluorescence anisotropy, r(t) (eq 5), which can decay in time
due to the rotational motion of the molecules and consequently
leads to depolarization of the fluorescence can be fitted to single
exponential decay function to determine the rotational time
constant (τrot) of the probe molecule (H33258).
25 The τrot
value is found to be 2.3 ns (inset of Figure 5b) when bound to the
micelle and 0.53 ns only in buffer, which is consistent with the
values reported earlier.26 The absorption spectrum of RF broadly
overlaps with the emission of H33258 bound to the SDS micelle
(Figure 5a). The decrease in steady-state and time-resolved
emission of H33258, bound to the micellar system, upon
addition of RF is shown in the inset of Figure 5a,b, respectively.
The efficiency of energy transfer is calculated by using eq 4b and
found to be 72%. The estimated F€orster distance (R0), utilizing
eq 1, and donor (H33258)-acceptor (RF) distance (r) are
found to be 40 and 34 Å, respectively (at 25 C). The observation
indicates simultaneous binding of the two drugs to the micelle
at room temperature.
To study the thermal stability of the drug binding to the SDS
micelle, we have performed picosecond-resolved temperature
dependent FRET experiments, as shown in Figure 6. From the
temperature dependent fluorescence anisotropy of the donor
H33258 bound to the micelle it is evident that the dynamics of
anisotropy becomes faster with increasing temperature. The
rotational relaxation time (τrot) of the probe is related to the
local microviscosity (ηm) of the probe environment according to
the Stokes-Einstein-Debye equation (SED) as
τrot ¼ ηmVhkBT ð6Þ
where kB is the Boltzmann constant, T is the absolute tempera-
ture, and Vh is the hydrodynamic volume of the probe. It is very
clear from this equation and the earlier report that the value of
rotational time constant (τrot) is supposed to decrease with
increasing temperature.33 This is due to the increased thermal
Figure 6. The picosecond-resolved fluorescence transients of H-SDS
(H33258-SDS) in absence (green) and in presence (red) of acceptor
RF (excitation at 375 nm) at (a) 20 C. Inset shows the fluorescence
anisotropy, r(t) of H-SDS complex at 20 C; (b) 55 C. Inset shows the
fluorescence anisotropy, r(t) of H-SDS complex at 55 C.
Table 1. Temperature-Dependent Fluorescence Lifetimes
(τi) and Their Respective Amplitudes (amp %), Rotational
Time Constant [τrot], F€orster Resonance Energy Transfer
(FRET) Efficiency (E), and FRET Distance (r) of H33258
(H-SDS) in SDSMicelle and H33258 (H-SDS-RF) in SDS
Micelle-Rifampicin (RF) Complexa
systems temp (C) τi (ns) (amp %) τav (ns) [τrot] (ns) E (%) r (Å)
H-SDS 20 4.1 (81%) 3.8 2.4
0.05 (19%)
H-SDS-RF 20 3.3 (16%) 0.8 76 33
0.91 (29%)
0.16 (55%)
H-SDS 25 4.0 (84%) 3.5 2.3
1.6 (12%)
0.17 (4%)
H-SDS-RF 25 3.5 (19%) 0.9 72 34
0.93 (30%)
0.10 (51%)
H-SDS 45 3.9 (65%) 2.9 1.2
1.61 (23%)
0.08 (12%)
H-SDS-RF 45 3.4 (21%) 1 65 36
0.87 (28%)
0.09 (51%)
H-SDS 55 3.8 (61%) 2.8 1
1.59 (29%)
0.08 (10%)
H-SDS-RF 55 3.2 (26%) 1.1 60 37
0.85 (28%)
0.08 (46%)
aThe systems are excited at 375 nm and decay collected at 475 nm.
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motion of the surfactant molecules with increasing temperature,
which in turn causes a decrease in the microviscosity of the
environment experienced by the probe (H33258) in the micellar
solution. Decrease in energy transfer efficiency and increase in
donor (H33258)-acceptor (RF) distance with increasing tem-
perature is evident from Table 1. An attempt to fit the fluores-
cence transients using biexponential functions also reveals
reasonable good fitting yielding similar donor-acceptor dis-
tances; however, energy transfer efficiencies are found to be
71% (at 20 C) and 43% (at 55 C).
It is known that RF is a specific inhibitor of bacterial RNA
polymerase and inhibits the process of transcription at the level of
initiation.13-16 It is also known that RF forms a 1:1 complex with
RNA polymerase.34 However, the possibility of direct interaction
of the drug with DNA is not investigated until now. To study the
interaction of DNA with RF we have used the fluorescence of
synthesized dodecamer-bound minor groove binder, drug
H3325835 in RF solution. Figure 7a shows the steady-state
emission of the DNA-bound H33258 in presence of varying
concentrations of RF and in absence of RF as well. It is clear from
Figure 7a that H33258-DNA fluorescence is significantly
decreased upon increasing the concentration of RF in the
solution and additionally a hump at 505 nm (similar to the
fluorescence peak in bulk water) is observed at higher concen-
trations of RF. The observation is consistent with the fact that a
small amount of H33258 is being detached from DNA in the
presence of RF. In the Figure 7b, the fluorescence transients of
H33258 in the dodecamer DNA without and with RF are shown.
The slower rotational depolarization decay in the inset of
Figure 7b indicates the attachment of the drug H33258 to the
DNA minor groove. Insignificant change in the fluorescence
lifetime of the probe H33258 bound to DNA in the presence of
RF clearly rules out the possibility of any direct interaction of RF
with the DNA. To reconfirm the competitive nature of the DNA
binding of RF, CD spectroscopy has also been utilized. However,
the CD spectrum of dodecamer DNA or RF upon mixing shows
insignificant change compared to spectrum of the DNA and RF
in bulk buffer. Thus, it is evident from the CD spectroscopy data
that RF probably does not have any direct interaction with the
DNA. Although a firm conclusion of the detachment of H33258
and lack of direct interaction of RF with the DNA invites more
experiments, one of the possible causes could be significant
alteration in the nature of DNA hydration in presence of RF in
the solution.36
’CONCLUSION
In this report we have explored the binding of an antitubercu-
losis drug RF to a model anionic SDS micelle. We have utilized
dynamic light scattering and conductometric studies to charac-
terize the structural changes of the SDS micelle upon binding of
RF. Additionally, circular dichroism spectroscopy has been
employed to characterize the binding of the drug to the micelle.
The temperature-dependent studies on the drugmicelle complex
reveal the partial detachment of the drug from the micelle at
elevated temperature and also that the structural integrity of the
complex is maintained throughout the range of temperature
studied. The strong absorption band in the visible region of the
drug RF has been employed to monitor resonance energy
transfer from an antihelminthic fluorescent drug H33258 at the
micellar surface. F€orster resonance energy transfer confirms the
simultaneous binding of the two drugs to the micelle. The study
at various temperatures confirms that the location and efficiency
of drug binding to the micelle change significantly. Steady-state
and time-resolved studies on a synthesized DNA-bound H33258
in RF solution indicate that H33258 detaches from the DNA
upon addition of RF and CD studies rules out the interaction of
DNA with the drug RF. Our spectroscopic studies are expected
to find their relevance in the exploration of interaction of the
important hydrophobic drug RF with other macromolecular
assemblies for the discovery of better drug-vehicle for the
sparingly aqueous soluble drug RF.
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Figure 7. (a) Steady-state fluorescence spectra of DNA-bound H33258
(H-DNA) with increasing concentration of RF. (b) The picosecond-
resolved fluorescence transients of H33258-DNA in absence (blue)
and in presence (pink) of acceptor RF (H-DNA-RF) (excited at
375 nm and decay collected at 450 nm). Inset shows the fluorescence
anisotropy, r(t) of H33258-DNA complex.
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